TABLE 2.
Clinical efficacy of various treatment alternatives in vitiligo
| N | MARKED RESPONSE | GOOD RESPONSE | MODERATE RESPONSE | MILD RESPONSE | NO RESPONSE | |
|---|---|---|---|---|---|---|
| Phototherapy | 1,996 | 954 (47.8%) | 373 (18.7%) | 327 (16.4%) | 330 (16.5%) | 12 (0.6%) |
| Phototherapy with topical therapy | 1,083 | 253 (23.4%) | 377 (34.8%) | 176 (16.3%) | 269 (24.8%) | 8 (0.7%) |
| Mono-phototherapy | 913 | 67 (7.3%) | 396 (43.4%) | 179 (19.6%) | 265 (29.0%) | 6 (0.7%) |
| Topical monotherapy | 1,004 | 88 (8.7%) | 417 (41.5%) | 245 (24.4%) | 250 (24.9%) | 4 (0.4%) |
| Subtypes of phototherapy-treated patients | ||||||
| Segmental | 347 | 34 (9.8%) | 213 (61.4%) | 33 (9.5%) | 66 (19%) | 1 (0.3%) |
| Acrofacial | 312 | 15 (4.8%) | 245 (78.5%) | 21 (6.7%) | 28 (9.0%) | 3 (1.0%) |
| Focal | 606 | 116 (19.1%) | 256 (42.4%) | 125 (20.6%) | 102 (16.8%) | 7 (1.2%) |
| Vulgaris | 731 | 133 (18.2%) | 156 (21.3%) | 298 (40.8%) | 138 (18.9%) | 6 (0.8%) |
| Therapy | ||||||
| Psoralen and ultraviolet A | 367 | 124 (33.8%) | 112 (30.5%) | 62 (16.9%) | 67 (18.3%) | 2 (0.5%) |
| Narrow band ultraviolet B | 978 | 184 (18.8%) | 304 (31.1%) | 196 (20.0%) | 288 (29.4%) | 6 (0.6%) |
| Excimer | 651 | 65 (10.0%) | 440 (67.6%) | 69 (10.6%) | 75 (11.5%) | 2 (0.3%) |